C57BL/6NCya-Tnfsf14em1/Cya
Common Name:
Tnfsf14-KO
Product ID:
S-KO-10257
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tnfsf14-KO
Strain ID
KOCMP-50930-Tnfsf14-B6N-VA
Gene Name
Product ID
S-KO-10257
Gene Alias
HVEM-L; HVEML; LIGHT; LTg; Ly113; Tnlg1d
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
17
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Tnfsf14em1/Cya mice (Catalog S-KO-10257) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000005976
NCBI RefSeq
NM_019418
Target Region
Exon 1~4
Size of Effective Region
~3.6 kb
Detailed Document
Overview of Gene Research
Tnfsf14, also known as LIGHT (Lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells), is a crucial member of the tumor necrosis factor superfamily. It is involved in immunological regulation and fibrosis-related pathways. LIGHT is expressed in inflammatory effector cells and plays an important role in various biological processes, including immune-tumor interactions, tissue fibrosis, and metabolic regulation [1-10]. Genetic models, such as knockout (KO) mouse models, have been instrumental in studying its functions.
In KO mouse models, Tnfsf14-deficient (Tnfsf14-/-) mice are protected from ovariectomy-dependent bone loss, suggesting that LIGHT mediates bone loss induced by estrogen deficiency [2]. In adipose tissue studies, LIGHT deficiency in mice promoted obesity during high-fat diet feeding and accelerated browning in the subcutaneous white adipose tissue during acute cold stress, indicating its role in regulating adipose tissue homeostasis [3]. In the context of cancer, LIGHT co-expressed chimeric antigen receptor T (LIGHT CAR-T) cells showed enhanced anti-tumor efficacy and infiltration compared to conventional CAR-T cells, revealing its potential in reconstituting a high immune-infiltrated tumor microenvironment [1].
In conclusion, Tnfsf14 is essential in multiple biological processes. Model-based research, especially using Tnfsf14 KO mouse models, has revealed its roles in diseases such as postmenopausal osteoporosis, obesity-related metabolic disorders, and cancer. These findings contribute to understanding disease mechanisms and may offer potential therapeutic targets for these conditions.
References:
1. Zhang, Na, Liu, Xiaohong, Qin, Juliang, Liu, Mingyao, Du, Bing. 2023. LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 2575-2590. doi:10.1016/j.ymthe.2023.06.015. https://pubmed.ncbi.nlm.nih.gov/37408308/
2. Brunetti, Giacomina, Storlino, Giuseppina, Oranger, Angela, Grano, Maria, Colucci, Silvia. 2020. LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss. In The Journal of pathology, 250, 440-451. doi:10.1002/path.5385. https://pubmed.ncbi.nlm.nih.gov/31990039/
3. Kou, Yanbo, Liu, Qingya, Liu, Wenli, Liu, Zhuanzhuan, Wang, Yugang. 2018. LIGHT/TNFSF14 signaling attenuates beige fat biogenesis. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33, 1595-1604. doi:10.1096/fj.201800792R. https://pubmed.ncbi.nlm.nih.gov/30148680/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen